Lv63
2720 积分 2021-06-15 加入
New frontier in albumin replacement therapy
2个月前
已完结
Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitors
2个月前
已完结
Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
2个月前
已完结
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
2个月前
已完结
ABCA4 regulates mitophagy in lung adenocarcinoma progression via AMPK pathway by modulating TMSB4X
3个月前
已完结
Icotinib in a lung adenocarcinoma patient with acquired EGFR 19del/C797S mutation-mediated resistance to osimertinib: a case report
3个月前
已完结
Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer
3个月前
已完结
Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash
4个月前
已完结
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence
4个月前
已完结
Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
5个月前
已完结
皖公网安备34019202002308
